Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Author
Log in
Sign up
GR
Gayathri Ravi
Author with expertise in Diagnosis and Treatment of Multiple Myeloma
Achievements
This user has not unlocked any achievements yet.
Key Stats
Upvotes received:
0
Publications:
12
(0% Open Access)
Cited by:
0
h-index:
6
/
i10-index:
3
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Overview
Publications
12
Peer Reviews
Comments
Grants
Publications
0
Phase 2 Trial of Siltuximab for the Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR-T Cell Therapy
Mayur Narkhede
et al.
Nov 5, 2024
Oncology
Immunology
0
Paper
Oncology
Immunology
0
Save
0
Factors Associated with Post-Transplant Complications Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
Apoorva Doshi
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Decisional Regret Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
Apoorva Doshi
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Real World Evidence on Patient Reported Outcomes Among Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Regimens in Frontline (1L)
Smith Giri
et al.
Nov 5, 2024
Oncology
Molecular Biology
0
Paper
Oncology
Molecular Biology
0
Save
0
Combination Regimens in MM Post Autologous Hematopoietic Cell Transplantation (AHCT) to Eliminate MRD Utilizing Iberdomide (COMMANDER): Results of Dose-Finding Component of a Phase 1b/2 Trial
Natalie Callander
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Longitudinal Trajectories of Patient-Reported Outcomes Among Older Adults with Multiple Myeloma (MM) Following Autologous Stem Cell Transplantation (ASCT)
Victoria Badia
et al.
Nov 5, 2024
Internal Medicine
Clinical Psychology
0
Paper
Internal Medicine
Clinical Psychology
0
Save
0
Functional Decline Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoetic Stem Cell Transplantation
Apoorva Doshi
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Implications of MRD Progression in Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Therapy and Autologous Stem Cell Transplantation
Luciano Costa
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)
Smith Giri
et al.
Nov 5, 2024
Oncology
Molecular Biology
0
Paper
Oncology
Molecular Biology
0
Save
0
Pharmacodynamic Profiles of Patients (Pts) with Newly Diagnosed (ND) Vs Relapsed/Refractory Multiple Myeloma (RRMM) Who Received Teclistamab (Tec) or Talquetamab (Tal) Plus Daratumumab (Dara) and Lenalidomide (Len) in the Phase 1b Majestec-2 and Monumental-2 Studies
Diana Cortes
et al.
Nov 5, 2024
Oncology
Internal Medicine
0
Paper
Oncology
Internal Medicine
0
Save
Load More